Acer Medical Inc.

Acer Medical Inc. is a healthcare technology company specializing in artificial intelligence-driven diagnostic and screening solutions for the medical sector. Founded in 2018 and headquartered in New Taipei City, Taiwan, the company delivers innovative software products—including VeriSee DR for diabetic retinopathy detection, VeriSee AMD for age-related macular degeneration, and VeriOsteo OP for bone mineral density assessment—to address critical needs in medical diagnostics and early disease identification. As a subsidiary of the Acer Group, Acer Medical unites expertise in AI, software development, and clinical data analytics to empower healthcare professionals with actionable insights and streamline patient care. The company’s solutions, validated by multiple international regulatory approvals and industry certifications, have been deployed extensively across hospitals and clinics, underscoring its role in advancing the adoption of intelligent, accessible healthcare technologies throughout Asia. Through a focus on practical medical impact and compliance with stringent quality standards, Acer Medical Inc. contributes to addressing resource shortages and inefficiencies in clinical environments, aiming to make cutting-edge diagnostic support more widely available.